Editors' ChoiceAsthma

Target practice in severe asthma

+ See all authors and affiliations

Science Translational Medicine  29 Mar 2017:
Vol. 9, Issue 383, eaan0769
DOI: 10.1126/scitranslmed.aan0769

You are currently viewing the abstract.

View Full Text

Abstract

The NLRP3 inflammasome/caspase-1/IL-1β axis may be a therapeutic target in severe steroid-resistant asthma.

View Full Text